• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤黑色素瘤与非霍奇金淋巴瘤之间关联的证据。

Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.

作者信息

Goggins W B, Finkelstein D M, Tsao H

机构信息

Department of Mathematics, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.

出版信息

Cancer. 2001 Feb 15;91(4):874-80. doi: 10.1002/1097-0142(20010215)91:4<874::aid-cncr1076>3.0.co;2-o.

DOI:10.1002/1097-0142(20010215)91:4<874::aid-cncr1076>3.0.co;2-o
PMID:11241258
Abstract

BACKGROUND

Over the past 2 decades both cutaneous melanoma (CM) and non-Hodgkin lymphoma (NHL) incidence rates have increased substantially. One approach to better understanding the etiologic basis for these increases is to examine the risk of NHL in CM survivors and the risk of CM in NHL survivors.

METHODS

To explore the possible association between CM and NHL, the authors followed cohorts of CM and NHL patients registered through the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program between 1973 and 1996 and identified patients who developed CM after NHL and NHL after CM. The number of observed cases then were compared with the number of expected cases to see if CM survivors were at an increased risk of NHL or if NHL survivors were at an increased risk of CM.

RESULTS

Between 1973 and 1996, 54,803 CM patients and 62,597 NHL patients who met the authors' inclusion criteria were identified through SEER. The authors found statistically significant elevated risks of NHL among CM survivors (standardized incidence ratio [SIR], 1.42; 95% confidence interval [CI], 1.23-1.63) and CM among NHL survivors (SIR, 1.75; 95% CI, 1.48-2.07).

CONCLUSIONS

These results support an association between CM and NHL. Although detection bias and posttherapy effects may explain part of this association, shared genetic or etiologic factors, such as sunlight exposure, also may play a role.

摘要

背景

在过去20年中,皮肤黑色素瘤(CM)和非霍奇金淋巴瘤(NHL)的发病率均大幅上升。更好地理解这些上升的病因基础的一种方法是研究CM幸存者患NHL的风险以及NHL幸存者患CM的风险。

方法

为了探索CM与NHL之间可能存在的关联,作者对1973年至1996年间通过美国国立癌症研究所的监测、流行病学和最终结果(SEER)计划登记的CM和NHL患者队列进行了随访,并确定了在患NHL后发生CM以及在患CM后发生NHL的患者。然后将观察到的病例数与预期病例数进行比较,以查看CM幸存者患NHL的风险是否增加,或者NHL幸存者患CM的风险是否增加。

结果

在1973年至1996年间,通过SEER确定了54,803例符合作者纳入标准的CM患者和62,597例NHL患者。作者发现CM幸存者患NHL的风险有统计学意义的升高(标准化发病比[SIR],1.42;95%置信区间[CI],1.23 - 1.63),以及NHL幸存者患CM的风险有统计学意义的升高(SIR,1.75;95%CI,1.48 - 2.07)。

结论

这些结果支持CM与NHL之间存在关联。尽管检测偏倚和治疗后效应可能解释了这种关联的一部分,但共同的遗传或病因因素,如阳光照射,也可能起作用。

相似文献

1
Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.皮肤黑色素瘤与非霍奇金淋巴瘤之间关联的证据。
Cancer. 2001 Feb 15;91(4):874-80. doi: 10.1002/1097-0142(20010215)91:4<874::aid-cncr1076>3.0.co;2-o.
2
Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.非霍奇金淋巴瘤幸存者中黑色素瘤的危险因素
J Clin Oncol. 2015 Oct 1;33(28):3096-104. doi: 10.1200/JCO.2014.60.2094. Epub 2015 Aug 3.
3
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.皮肤黑色素瘤和特定淋巴肿瘤的相互风险:第二癌症发生和生存。
J Natl Cancer Inst. 2018 Nov 1;110(11):1248-1258. doi: 10.1093/jnci/djy052.
4
Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.诊断为皮肤黑色素瘤后的第二原发性恶性肿瘤风险:一项基于人群的研究。
J Am Acad Dermatol. 2010 May;62(5):757-67. doi: 10.1016/j.jaad.2009.07.039. Epub 2010 Mar 12.
5
Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.特定非霍奇金淋巴瘤亚型成年幸存者中由传染性病因引起的恶性肿瘤风险。
Blood Adv. 2019 Jul 9;3(13):1961-1969. doi: 10.1182/bloodadvances.2019030924.
6
Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.蕈样肉芽肿和塞扎里综合征患者的继发性淋巴瘤及其他恶性肿瘤:基于人群和临床队列的证据
Arch Dermatol. 2007 Jan;143(1):45-50. doi: 10.1001/archderm.143.1.45.
7
Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.原位和侵袭性皮肤黑色素瘤患者的继发原发性癌症。
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S69-77. doi: 10.1016/j.jaad.2011.04.033.
8
A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma.一项关于皮肤黑色素瘤和非霍奇金淋巴瘤患者的单机构病例系列研究。
J Am Acad Dermatol. 2002 Jan;46(1):55-61. doi: 10.1067/mjd.2001.118353.
9
Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.慢性淋巴细胞白血病患者中恶性黑色素瘤及其他罕见皮肤癌的发病率增加。
Int J Dermatol. 2015 Aug;54(8):e287-93. doi: 10.1111/ijd.12564. Epub 2015 Mar 13.
10
Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).霍奇金淋巴瘤和非霍奇金淋巴瘤长期幸存者的后续恶性肿瘤:德国癌症登记数据的汇总分析(1990-2012 年)。
Br J Haematol. 2017 Apr;177(2):226-242. doi: 10.1111/bjh.14530. Epub 2017 Jan 20.

引用本文的文献

1
Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors-A Literature Review.黑色素瘤作为血液系统癌症幸存者的后续原发性恶性肿瘤——文献综述
J Clin Med. 2024 Aug 1;13(15):4501. doi: 10.3390/jcm13154501.
2
Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective.黑色素瘤幸存者中的同步和异时性多原发癌:性别视角。
Front Public Health. 2023 Jun 16;11:1195458. doi: 10.3389/fpubh.2023.1195458. eCollection 2023.
3
Risk of Second Primary Malignancies in Melanoma Survivors: A Population-Based Study.
黑色素瘤幸存者发生第二原发性恶性肿瘤的风险:一项基于人群的研究。
Cancers (Basel). 2023 Jun 5;15(11):3056. doi: 10.3390/cancers15113056.
4
Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry.原发性皮肤B细胞淋巴瘤患者皮肤黑色素瘤和默克尔细胞癌的发病率:一项基于监测、流行病学和最终结果(SEER)登记处的人群研究。
Front Med (Lausanne). 2023 Apr 6;10:1110511. doi: 10.3389/fmed.2023.1110511. eCollection 2023.
5
PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells.黑色素瘤肿瘤微环境细胞中PD-L1、CD4+和CD8+肿瘤浸润淋巴细胞(TILs)的表达谱
J Pers Med. 2023 Jan 27;13(2):221. doi: 10.3390/jpm13020221.
6
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.皮肤黑色素瘤和特定淋巴肿瘤的相互风险:第二癌症发生和生存。
J Natl Cancer Inst. 2018 Nov 1;110(11):1248-1258. doi: 10.1093/jnci/djy052.
7
Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.非霍奇金淋巴瘤幸存者中黑色素瘤的危险因素
J Clin Oncol. 2015 Oct 1;33(28):3096-104. doi: 10.1200/JCO.2014.60.2094. Epub 2015 Aug 3.
8
Second malignancies in patients with primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤患者的第二原发恶性肿瘤。
Neuro Oncol. 2015 Jan;17(1):129-35. doi: 10.1093/neuonc/nou105. Epub 2014 Jun 19.
9
Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients.B细胞淋巴瘤患者DNA修复与氧化应激基因的多态性
Biomed Rep. 2013 Jan;1(1):151-155. doi: 10.3892/br.2012.31. Epub 2012 Oct 25.
10
Risk of subsequent primary tumor development in melanoma patients.黑色素瘤患者继发原发性肿瘤的风险。
Pathol Oncol Res. 2013 Oct;19(4):805-10. doi: 10.1007/s12253-013-9647-8. Epub 2013 May 17.